These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9506739)

  • 1. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.
    McConnell DS; Wang Q; Sluss PM; Bolf N; Khoury RH; Schneyer AL; Midgley AR; Reame NE; Crowley WF; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Mar; 83(3):851-8. PubMed ID: 9506739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
    Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
    Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.
    Schneyer AL; Rzucidlo DA; Sluss PM; Crowley WF
    Endocrinology; 1994 Aug; 135(2):667-74. PubMed ID: 8033815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
    Schneyer AL; Fujiwara T; Fox J; Welt CK; Adams J; Messerlian GM; Taylor AE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3319-30. PubMed ID: 10999828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
    Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
    Reame NE; Wyman TL; Phillips DJ; de Kretser DM; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3302-7. PubMed ID: 9745445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.
    Muttukrishna S; Fowler PA; George L; Groome NP; Knight PG
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3328-34. PubMed ID: 8784092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of follistatin production by rat granulosa cells in vitro.
    Shintani Y; Dyson M; Drummond AE; Findlay JK
    Endocrinology; 1997 Jun; 138(6):2544-51. PubMed ID: 9165047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.
    Schneyer AL; Hall HA; Lambert-Messerlian G; Wang QF; Sluss P; Crowley WF
    Endocrinology; 1996 Jan; 137(1):240-7. PubMed ID: 8536619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.
    Lambert-Messerlian GM; Hall JE; Sluss PM; Taylor AE; Martin KA; Groome NP; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1994 Jul; 79(1):45-50. PubMed ID: 8027251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin A and follistatin are dynamically regulated during human pregnancy.
    Woodruff TK; Sluss P; Wang E; Janssen I; Mersol-Barg MS
    J Endocrinol; 1997 Feb; 152(2):167-74. PubMed ID: 9071973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women.
    Wakatsuki M; Shintani Y; Abe M; Liu ZH; Shitsukawa K; Saito S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):630-4. PubMed ID: 8636280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid.
    Knight PG; Muttukrishna S; Groome NP
    J Endocrinol; 1996 Feb; 148(2):267-79. PubMed ID: 8699141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 2-macroglobulin is a binding protein of inhibin and activin.
    Vaughan JM; Vale WW
    Endocrinology; 1993 May; 132(5):2038-50. PubMed ID: 7682939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activin-binding proteins in human serum and follicular fluid.
    Schneyer AL; O'Neil DA; Crowley WF
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1320-4. PubMed ID: 1592877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human plasma free activin and inhibin levels during the menstrual cycle.
    Demura R; Suzuki T; Tajima S; Mitsuhashi S; Odagiri E; Demura H; Ling N
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1080-2. PubMed ID: 8473385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.
    de Winter JP; ten Dijke P; de Vries CJ; van Achterberg TA; Sugino H; de Waele P; Huylebroeck D; Verschueren K; van den Eijnden-van Raaij AJ
    Mol Cell Endocrinol; 1996 Jan; 116(1):105-14. PubMed ID: 8822271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of inhibin pro-alpha C-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay.
    Groome NP; Illingworth PJ; O'Brien M; Priddle J; Weaver K; McNeilly AS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2926-32. PubMed ID: 7559876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
    Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.